OTCQB
HCAND

Halo Labs Inc

Healthcare Providers & Services
Healthcare

Prices are adjusted according to historical splits.

Halo Labs Inc Stock Price

Vitals

Today's Low:
$0.0165
Today's High:
$0.0191
Open Price:
$0.0166
52W Low:
$0.0144
52W High:
$0.4575
Prev. Close:
$0.0144
Volume:
35542

Company Statistics

Market Cap.:
$1.23 million
Book Value:
7.778
Revenue TTM:
$28.34 million
Operating Margin TTM:
-126.68%
Gross Profit TTM:
$4.45 million
Profit Margin:
0%
Return on Assets TTM:
-16.5%
Return on Equity TTM:
-97.45%

Company Profile

Halo Labs Inc had its IPO on under the ticker symbol HCAND.

The company operates in the Healthcare sector and Healthcare Providers & Services industry. Halo Labs Inc has a staff strength of 276 employees.

Stock update

Shares of Halo Labs Inc opened at $0.02 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.02 - $0.02, and closed at $0.02.

This is a +14.58% increase from the previous day's closing price.

A total volume of 35,542 shares were traded at the close of the day’s session.

In the last one week, shares of Halo Labs Inc have slipped by -30.38%.

Halo Labs Inc's Key Ratios

Halo Labs Inc has a market cap of $1.23 million, indicating a price to book ratio of 0.0103 and a price to sales ratio of 0.0435.

In the last 12-months Halo Labs Inc’s revenue was $28.34 million with a gross profit of $4.45 million and an EBITDA of $-33465188. The EBITDA ratio measures Halo Labs Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Halo Labs Inc’s operating margin was -126.68% while its return on assets stood at -16.5% with a return of equity of -97.45%.

In Q3, Halo Labs Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 36.6%.

Halo Labs Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-3.045 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Halo Labs Inc’s profitability.

Halo Labs Inc stock is trading at a EV to sales ratio of 0.6382 and a EV to EBITDA ratio of -0.2047. Its price to sales ratio in the trailing 12-months stood at 0.0435.

Halo Labs Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$110.97 million
Total Liabilities
$18.43 million
Operating Cash Flow
$-29797.00
Capital Expenditure
$29797
Dividend Payout Ratio
0%

Halo Labs Inc ended 2024 with $110.97 million in total assets and $0 in total liabilities. Its intangible assets were valued at $110.97 million while shareholder equity stood at $80.19 million.

Halo Labs Inc ended 2024 with $0 in deferred long-term liabilities, $18.43 million in other current liabilities, 273080293.00 in common stock, $-209538161.00 in retained earnings and $0 in goodwill. Its cash balance stood at $1.71 million and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $10.51 million.

Halo Labs Inc’s total current assets stands at $34.89 million while long-term investments were $21.81 million and short-term investments were $0. Its net receivables were $7.44 million compared to accounts payable of $12.31 million and inventory worth $16.47 million.

In 2024, Halo Labs Inc's operating cash flow was $-29797.00 while its capital expenditure stood at $29797.

Comparatively, Halo Labs Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$0.02
52-Week High
$0.4575
52-Week Low
$0.0144
Analyst Target Price
$

Halo Labs Inc stock is currently trading at $0.02 per share. It touched a 52-week high of $0.4575 and a 52-week low of $0.4575. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.06 and 200-day moving average was $3.33 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 2318.2% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Halo Labs Inc

The stock symbol (also called stock or share ticker) of Halo Labs Inc is HCAND

The IPO of Halo Labs Inc took place on

Similar Industry Stocks (Healthcare Providers & Services)

Last Price
Chg
Chg%
$1750.45
-102.55
-5.53%
$1.73
-0.06
-3.35%
$226.05
-17.7
-7.26%
$96.6
1.34
+1.41%
$530.15
-33.9
-6.01%
$22.58
-0.09
-0.4%
Sony Corp (SNEJF)
$85.34
0.64
+0.76%
$6.96
0.01
+0.14%
$4.32
-0.44
-9.24%
$753
-40.45
-5.1%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Halo Collective Inc. operates as a cannabis cultivation, manufacturing, and distribution company that grows, extracts, and processes cannabis flower, oils, and concentrates in the United States. It also offers edible products, including cannabis-infused gummies and a syrup-based drink in California and Oregon. In addition, the company markets branded and private label products. It sells its cannabis products principally to dispensaries under Hush, Mojave, and Exhale brands. The company serves licensed retailers and wholesalers. It has a strategic partnership with High Tide Inc; and with OG DNA Genetics Inc to develop genetics in Oregon. The company was formerly known as Halo Labs Inc. and changed its name to Halo Collective Inc. in January 2021. Halo Collective Inc. was founded in 2016 and is headquartered in Toronto, Canada.

Address

77 King Street West, Toronto, ON, Canada, M5K 0A1